Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors. 2023

Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China.

The development of dual inhibitors of HIV-1 protease and reverse transcriptase is an attractive strategy for multi-target therapeutic of AIDS, which may be privileged in delaying the occurrence of drug resistance. We herein designed a novel kind of dual inhibitors with benzofuran or indole cores. Biological results showed that a number of inhibitors displayed significant activity against both HIV-1 protease and reverse transcriptase. Among which, inhibitor 10f exhibited a good correlation with an approximate ratio of 1: 2 between the two enzymes. Furthermore, the dual inhibitors illustrated similar potency against both the wild-type virus and drug-resistant mutant. In addition, the molecular dynamic simulation studies verified the dual actions of such inhibitors.

UI MeSH Term Description Entries
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
April 2013, Bioorganic & medicinal chemistry,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
January 2021, Bioorganic & medicinal chemistry letters,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
August 2013, Organic and medicinal chemistry letters,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
August 2014, ChemMedChem,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
January 2015, Archiv der Pharmazie,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
December 2013, Organic and medicinal chemistry letters,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
November 2009, Yao xue xue bao = Acta pharmaceutica Sinica,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
April 2017, Bioorganic chemistry,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
April 1994, The Journal of biological chemistry,
Mei Zhu, and Qi Shan, and Ling Ma, and Biao Dong, and Juxian Wang, and Guoning Zhang, and Minghua Wang, and Jinming Zhou, and Shan Cen, and Yucheng Wang
May 2000, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!